Skip to main content

SOLUCIONES PARA LA MEJORA DE LA EFICIENCIA Y SEGURIDAD DEL PANCREAS ARTIFICIAL MEDIANTE ARQUITECTURAS DE CONTROL MULTIVARIABLE TOLERANTES A FALLOS

DPI2016-78831-C2-1-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 26
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes

  • Herrero, P.
  • Oliver, N.
  • Georgiou, P.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Type 1 diabetes is an autoimmune condition characterised by a pancreatic insulin secretion deficit, resulting in high blood glucose concentrations, which can lead to micro- and macrovascular complications. Type 1 diabetes also leads to impaired glucagon production by the pancreatic -cells, which acts as a counter-regulatory hormone to insulin. A closed-loop system for automatic insulin and glucagon delivery, also referred to as an artificial pancreas, has the potential to reduce the self-management burden of type 1 diabetes and reduce the risk of hypo- and hyperglycemia. To date, bihormonal closed-loop systems for glucagon and insulin delivery have been based on two independent controllers. However, in physiology, the secretion of insulin and glucagon in the body is closely interconnected by paracrine and endocrine associations. In this work, we present a novel biologically-inspired glucose control strategy that accounts for such coordination. An in silico study using an FDA-accepted type 1 simulator was performed to evaluate the proposed coordinated control strategy compared to its non-coordinated counterpart, as well as an insulin-only version of the controller. The proposed coordinated strategy achieves a reduction of hyperglycemia without increasing hypoglycemia, when compared to its non-coordinated counterpart., This work was supported by the Wellcome Trust; the Spanish Ministry of Economy and Competitiveness (MINECO) [grant number DPI2016-78831-C2-1-R]; the EU through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes

  • Viñals, Clara
  • Beneyto, Aleix
  • Hirata-Bertachi, Arthur
  • Vehí, Josep
  • Conget, Ignacio
  • Giménez, Marga
  • Martín-SanJosé, Juan-Fernando|||0000-0002-3247-6156
  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: To evaluate the safety and performance of a new multivariable closed-loop (MCL) glucose controller with automatic carbohydrate recommendation during and after unannounced and announced exercise in adults with type 1 diabetes (T1D). Research design and methods: A randomized, 3-arm, crossover clinical trial was conducted. Participants completed a heavy aerobic exercise session including three 15-minute sets on a cycle ergometer with 5 minutes rest in between. In a randomly determined order, we compared MCL control with unannounced (CLNA) and announced (CLA) exercise to open-loop therapy (OL). Adults with T1D, insulin pump users, and those with hemoglobin (Hb)A1c between 6.0% and 8.5% were eligible. We investigated glucose control during and 3 hours after exercise. Results: Ten participants (aged 40.8 +/- 7.0 years; HbA1c of 7.3 +/- 0.8%) participated. The use of the MCL in both closed-loop arms decreased the time spent <70 mg/dL of sensor glucose (0.0%, [0.0-16.8] and 0.0%, [0.0-19.2] vs 16.2%, [0.0-26.0], (%, [percentile 10-90]) CLNA and CLA vs OL respectively; P = 0.047, P = 0.063) and the number of hypoglycemic events when compared with OL (CLNA 4 and CLA 3 vs OL 8; P = 0.218, P = 0.250). The use of the MCL system increased the proportion of time within 70 to 180 mg/dL (87.8%, [51.1-100] and 91.9%, [58.7-100] vs 81.1%, [65.4-87.0], (%, [percentile 10-90]) CLNA and CLA vs OL respectively; P = 0.227, P = 0.039). This was achieved with the administration of similar doses of insulin and a reduced amount of carbohydrates. Conclusions: The MCL with automatic carbohydrate recommendation performed well and was safe during and after both unannounced and announced exercise, maintaining glucose mostly within the target range and reducing the risk of hypoglycemia despite a reduced amount of carbohydrate intake., This work has been partially funded by the Spanish Government under grants DPI2016-78831-C2-1-R, DPI2016-78831-C2-2-R, and FPU0244 2015; by the EU through FEDER funds; by the National Counsel of Technological and Scientific Development, CNPq-Brazil 207688/2014-1; and by the Government of Catalonia under 2017SGR1551. C.V. is the recipient of a grant from the Hospital Clinic i Universitari of Barcelona ("Premi Fi de Residencia 2018-2019").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Assessment of Seasonal Stochastic Local Models for Glucose Prediction without Meal Size Information under Free-Living Conditions

  • Prendin, Francesco
  • Del Favero, Simone
  • Sparacino, Giovanni
  • Facchinetti, Andrea
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Accurate blood glucose (BG) forecasting is key in diabetes management, as it allows preventive actions to mitigate harmful hypoglycemic/hyperglycemic episodes. Considering the encouraging results obtained by seasonal stochastic models in proof-of-concept studies, this work assesses the methodology in two datasets (open-loop and closed-loop) recorded in free-living conditions. First, similar postprandial glycemic profiles are grouped together with fuzzy C-means clustering. Then, a seasonal stochastic model is identified for each cluster. Finally, real-time BG forecasting is performed by weighting each model's prediction. The proposed methodology (named C-SARIMA) is compared to other linear and nonlinear black-box methods: autoregressive integrated moving average (ARIMA), its variant with input (ARIMAX), a feed-forward neural network (NN), and its modified version (NN-X) fed by BG, insulin, and carbohydrates (timing and dosing) information for several prediction horizons (PHs). In the open-loop dataset, C-SARIMA grants a median root-mean-squared error (RMSE) of 20.13 mg/dL (PH = 30) and 27.23 mg/dL (PH = 45), not significantly different from ARIMA and NN. Over a longer PH, C-SARIMA achieves an RMSE = 31.96 mg/dL (PH = 60) and RMSE = 33.91 mg/dL (PH = 75), significantly outperforming the ARIMA and NN, without significant differences from the ARIMAX for PH >= 45 and the NN-X for PH >= 60. Similar results hold on the closed-loop dataset: for PH = 30 and 45 min, the C-SARIMA achieves an RMSE = 21.63 mg/dL and RMSE = 29.67 mg/dL, not significantly different from the ARIMA and NN. On longer PH, the C-SARIMA outperforms the ARIMA for PH > 45 and the NN for PH > 60 without significant differences from the ARIMAX for PH >= 45. Although using less input information, the C-SARIMA achieves similar performance to other prediction methods such as the ARIMAX and NN-X and outperforming the CGM-only approaches on PH > 45min., This work was partially supported by the project "A noninvasive tattoo-based continuous GLUCOse Monitoring electronic system FOR Type-1 diabetes individuals (GLUCOMFORT)" (initiative "PRIN: Progetti di Rilevante Interesse Nazionale", call 2020, project ID: 2020X7XX2P) and through the initiative "Departments of Excellence" (Law 232/2016); Grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe", Grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033, and the mobility Grant PRX19/00463 funded by MCIN/AEI/10.13039/501100011033 for a research stay of J. Bondia at the University of Padova.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Seasonal Local Models for Glucose Prediction in Type 1 Diabetes

  • Montaser, Eslam
  • Rossetti, Paolo
  • Rashid, Mudassir
  • Cinar, Ali
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Linear empirical dynamic models have been widely used for blood glucose prediction and risks prevention in people with type 1 diabetes. More accurate blood glucose prediction models with longer prediction horizon (PH) are desirable to enable warnings to patients about imminent blood glucose changes with enough time to take corrective actions. In this study, a blood glucose prediction method is developed by integrating the predictions of a set of seasonal local models (each of them corresponding to different glucose profiles observed along historical data). In the modeling step, the number of sets and their corresponding glucose profiles characteristics are obtained by clustering techniques (Fuzzy C-Means). Then, Box-Jenkins methodology is used to identify a seasonal model for each set. Finally, blood glucose predictions of local models are integrated using different techniques. The proposed method is tested by using 18 60-h closed-loop experiments (including different exercise types and artificial pancreas strategies) and achieving mean absolute percentage error (MAPE) of 2.94%, 3.89%, 5.41%, 6.29% and 8.66% for 15-, 30-, 45-, 60-, and 90-min PHs, respectively., This work was supported in part by the Spanish Ministry of Economy and Competitiveness under Grants DPI2016-78831-C2-1-R, BES-2014-069253 and EEBB-I-17-12320, in part by the European Union through FEDER funds, and in part Universitat Politecnica de Valencia PAID-00-17 Program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Individual Categorisation of Glucose Profiles Using Compositional Data Analysis

  • Biagi, L.
  • Bertachi, A.
  • Giménez, M.
  • Conget, I.
  • Martín-Fernández, Josep Antoni
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The aim of this study was to apply a methodology based on compositional data analysis (CoDA) to categorise glucose profiles obtained from continuous glucose monitoring systems. The methodology proposed considers complete daily glucose profiles obtained from six patients with type 1 diabetes (T1D) who had their glucose monitored for eight weeks. The glucose profiles were distributed into the time spent in six different ranges. The time in one day is finite and limited to 24h, and the times spent in each of these different ranges are co-dependent and carry only relative information; therefore, CoDA is applied to these profiles. A K-means algorithm was applied to the coordinates obtained from the CoDA to obtain different patterns of days for each patient. Groups of days with relatively high time in the hypo and/or hyperglycaemic ranges and with different glucose variability were observed. Using CoDA of time in different ranges, individual glucose profiles were categorised into groups of days, which can be used by physicians to detect the different conditions of patients and personalise patient's insulin therapy according to each group. This approach can be useful to assist physicians and patients in managing the day-to-day variability that hinders glycaemic control., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has been partially supported by the Spanish Government MINECO through Grants DPI-2016-78831-C2-1-R, DPI2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7, 207688/2014-1 and EU through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Coordinated dual-hormone artificial pancreas with parallel control structure

  • Moscardo, Vanessa
  • Herrero, Pau
  • Giménez, Marga
  • Rossetti, Paolo
  • Georgiou, Pantelis
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Concomitant glucagon delivery in a dual-hormone artificial pancreas system might overcome the limitations of insulin-only systems, potentially leading to improved hypoglycemia mitigation. However, current dual-hormone systems have not shown clearly its superiority. This work presents a novel dual-hormone system based on a parallel control structure with intrinsic coordination among insulin and glucagon delivery. The proposed coordinated controller (CC) was compared with its non-coordinated counterpart (NCC) based on independent loops for the insulin and glucagon controllers, as done in current systems. To evaluate the benefits of coordination, CC and NCC shared the same insulin controller, differing solely on how glucagon is administered. An in-silico study using the UVA-Padova simulator, extended with variability sources, was performed. Three scenarios were considered, comprising meals, snacks and exercise. CC achieved superior performance with better values of times in ranges. Moreover, CC delivered lower glucagon doses than the two NCC tuning alternatives considered., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) through grant number DPI2016-78831-C2-1-R and the European Union through FEDER funds. Vanessa Moscardowas recipient of an FPU grant, FPU13/04253.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Artificial Pancreas System With Unannounced Meals Based on a Disturbance Observer and Feedforward Compensation

  • Sanz Diaz, Ricardo
  • García Gil, Pedro José|||0000-0002-1202-1269
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] This brief is focused on the closed-loop control of postprandial glucose levels of patients with type 1 diabetes mellitus after unannounced meals, which is still a major challenge toward a fully autonomous artificial pancreas. The main limitations are the delays introduced by the subcutaneous insulin pharmacokinetics and the glucose sensor, which typically leads to insulin overdelivery. Current solutions reported in the literature typically resort to meal announcement, which requires patient intervention. In this brief, a disturbance observer (DOB) is used to estimate the effect of unannounced meals, and the insulin pharmacokinetics is taken into account by means of a feedforward compensator. The proposed strategy is validated in silico with the UVa/Padova metabolic simulator. It is demonstrated how the DOB successfully estimates and counteracts not only the effect of meals but also the sudden drops in the glucose levels that may lead to hypoglycemia. For unannounced meals, results show a median time-in-range of 80% in a 30-day scenario with high carbohydrate content and large intrasubject variability. Optionally, users may decide to announce meals. In this case, considering severe bolus mismatch due to carbohydrate counting errors, the median time-in-range is increased up to 88%. In every case, hypoglycemia is avoided., This work was supported in part by the Ministerio de Economia y Competitividad under Grant DPI2016-78831-C2-1-R and in part by the European Union through FEDER Funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring

  • Ramkissoon, C.M.
  • Herrero, Pau
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. However, current AP developments are mainly hybrid closed-loop systems that include feed-forward actions triggered by the announcement of meals or exercise. The first step to fully closing the loop in the AP requires removing meal announcement, which is currently the most effective way to alleviate postprandial hyperglycemia due to the delay in insulin action. Here, a novel approach to meal detection in the AP is presented using a sliding window and computing the normalized cross-covariance between measured glucose and the forward difference of a disturbance term, estimated from an augmented minimal model using an Unscented Kalman Filter. Three different tunings were applied to the samemeal detection algorithm: (1) a high sensitivity tuning, (2) a trade-off tuning that has a high amount of meals detected and a low amount of false positives (FP), and (3) a low FP tuning. For the three tunings sensitivities 99 +/- 2%, 93 +/- 5%, and 47 +/- 12% were achieved, respectively. A sensitivity analysis was also performed and found that higher carbohydrate quantities and faster rates of glucose appearance result in favorable meal detection outcomes., This work was funded by the Spanish Government through grants DPI2016-78831-C2-1-R and DPI2016-78831-C2-2-R, the University of Girona through grant BR2014/51, and the European Union through Fondo Europeo de Desarrollo Regional (FEDER) Funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

STOCHASTIC SEASONAL MODELS FOR GLUCOSE PREDICTION IN TYPE 1 DIABETES

  • Montaser Roushdi Ali, Eslam
[ES] La diabetes es un importante problema de salud mundial, siendo una de las enfermedades no transmisibles más graves después de las enfermedades cardiovasculares, el cáncer y las enfermedades respiratorias crónicas. La prevalencia de la diabetes ha aumentado constantemente en las últimas décadas, especialmente en países de ingresos bajos y medios. Se estima que 425 millones de personas en todo el mundo tenían diabetes en 2017, y para 2045 este número puede aumentar a 629 millones. Alrededor del 10% de las personas con diabetes padecen diabetes tipo 1, caracterizada por una destrucción autoinmune de las células beta en el páncreas, responsables de la secreción de la hormona insulina. Sin insulina, la glucosa plasmática aumenta a niveles nocivos, provocando complicaciones vasculares a largo plazo. Hasta que se encuentre una cura, el manejo de la diabetes depende de los avances tecnológicos para terapias de reemplazo de insulina. Con la llegada de los monitores continuos de glucosa, la tecnología ha evolucionado hacia sistemas automatizados. Acuñados como "páncreas artificial", los dispositivos de control de glucosa en lazo cerrado suponen hoy en día un cambio de juego en el manejo de la diabetes. La investigación en las últimas décadas ha sido intensa, dando lugar al primer sistema comercial a fines de 2017, y muchos más están siendo desarrollados por las principales industrias de dispositivos médicos. Sin embargo, como dispositivo de primera generación, muchos problemas aún permanecen abiertos y nuevos avances tecnológicos conducirán a mejoras del sistema para obtener mejores resultados de control glucémico y reducir la carga del paciente, mejorando significativamente la calidad de vida de las personas con diabetes tipo 1. En el centro de cualquier sistema de páncreas artificial se encuentra la predicción de glucosa, tema abordado en esta tesis. La capacidad de predecir la glucosa a lo largo de un horizonte de predicción dado, y la estimación de las tendencias futuras de glucosa, es la característica más importante de cualquier sistema de páncreas artificial, para poder tomar medidas preventivas que eviten por completo el riesgo para el paciente. La predicción de glucosa puede aparecer como parte del algoritmo de control en sí, como en sistemas basados en técnicas de control predictivo basado en modelo (MPC), o como parte de un sistema de supervisión para evitar episodios de hipoglucemia. Sin embargo, predecir la glucosa es un problema muy desafiante debido a la gran variabilidad inter e intra-sujeto que sufren los pacientes, cuyas fuentes solo se entienden parcialmente. Esto limita las prestaciones predictivas de los modelos, imponiendo horizontes de predicción relativamente cortos, independientemente de la técnica de modelado utilizada (modelos fisiológicos, basados en datos o híbridos). La hipótesis de partida de esta tesis es que la complejidad de la dinámica de la glucosa requiere la capacidad de caracterizar grupos de comportamientos en los datos históricos del paciente que llevan naturalmente al concepto de modelado local. Además, la similitud de las respuestas en un grupo puede aprovecharse aún más para introducir el concepto clásico de estacionalidad en la predicción de glucosa. Como resultado, los modelos locales estacionales están en el centro de esta tesis. Se utilizan varias bases de datos clínicas que incluyen comidas mixtas y ejercicio para demostrar la viabilidad y superioridad de las prestaciones de este enfoque., [CA] La diabetisés un important problema de salut mundial, sent una de les malalties no transmissibles més greus després de les malalties cardiovasculars, el càncer i les malalties respiratòries cròniques. La prevalença de la diabetis ha augmentat constantment en les últimes dècades, especialment en països d'ingressos baixos i mitjans. S'estima que 425 milions de persones a tot el món tenien diabetis en 2017, i per 2045 aquest nombre pot augmentar a 629 milions. Al voltant del 10% de les persones amb diabetis pateixen diabetis tipus 1, caracteritzada per una destrucció autoimmune de les cèl·lules beta en el pàncrees, responsables de la secreció de l'hormona insulina. Sense insulina, la glucosa plasmàtica augmenta a nivells nocius, provocant complicacions vasculars a llarg termini. Fins que es trobi una cura, el maneig de la diabetis depén dels avenços tecnològics per a teràpies de reemplaçament d'insulina. Amb l'arribada dels monitors continus de glucosa, la tecnologia ha evolucionat cap a sistemes automatitzats. Encunyats com "pàncrees artificial", els dispositius de control de glucosa en llaç tancat suposen avui dia un canvi de joc en el maneig de la diabetis. La investigació en les últimes dècades ha estat intensa, donant lloc al primer sistema comercial a finals de 2017, i molts més estan sent desenvolupats per les principals indústries de dispositius mèdics. No obstant això, com a dispositiu de primera generació, molts problemes encara romanen oberts i nous avenços tecnològics conduiran a millores del sistema per obtenir millors resultats de control glucèmic i reduir la càrrega del pacient, millorant significativament la qualitat de vida de les persones amb diabetis tipus 1. Al centre de qualsevol sistema de pàncrees artificial es troba la predicció de glucosa, tema abordat en aquesta tesi. La capacitat de predir la glucosa al llarg d'un horitzó de predicció donat, i l'estimació de les tendències futures de glucosa, és la característica més important de qualsevol sistema de pàncrees artificial, per poder prendre mesures preventives que evitin completament el risc per el pacient. La predicció de glucosa pot aparèixer com a part de l'algoritme de control en si, com en sistemes basats en técniques de control predictiu basat en model (MPC), o com a part d'un sistema de supervisió per evitar episodis d'hipoglucèmia. No obstant això, predir la glucosa és un problema molt desafiant degut a la gran variabilitat inter i intra-subjecte que pateixen els pacients, les fonts només s'entenen parcialment. Això limita les prestacions predictives dels models, imposant horitzons de predicció relativament curts, independentment de la tècnica de modelatge utilitzada (models fisiològics, basats en dades o híbrids). La hipòtesi de partida d'aquesta tesi és que la complexitat de la dinàmica de la glucosa requereix la capacitat de caracteritzar grups de comportaments en les dades històriques del pacient que porten naturalment al concepte de modelatge local. A més, la similitud de les respostes en un grup pot aprofitar-se encara més per introduir el concepte clàssic d'estacionalitat en la predicció de glucosa. Com a resultat, els models locals estacionals estan al centre d'aquesta tesi. S'utilitzen diverses bases de dades clíniques que inclouen menjars mixtes i exercici per demostrar la viabilitat i superioritat de les prestacions d'aquest enfocament., [EN] Diabetes is a significant global health problem, one of the most serious noncommunicable diseases after cardiovascular diseases, cancer and chronic respiratory diseases. Diabetes prevalence has been steadily increasing over the past decades, especially in low- and middle-income countries. It is estimated that 425 million people worldwide had diabetes in 2017, and by 2045 this number may rise to 629 million. About 10% of people with diabetes suffer from type 1 diabetes, characterized by autoimmune destruction of the beta-cells in the pancreas, responsible for the secretion of the hormone insulin. Without insulin, plasma glucose rises to deleterious levels, provoking long-term vascular complications. Until a cure is found, the management of diabetes relies on technological developments for insulin replacement therapies. With the advent of continuous glucose monitors, technology has been evolving towards automated systems. Coined as "artificial pancreas", closed-loop glucose control devices are nowadays a game-changer in diabetes management. Research in the last decades has been intense, yielding a first commercial system in late 2017 and many more are in the pipeline of the main medical devices industry. However, as a first-generation device, many issues still remain open and new technological advancements will lead to system improvements for better glycemic control outputs and reduced patient's burden, improving significantly the quality of life of people with type 1 diabetes. At the core of any artificial pancreas system is glucose prediction, the topic addressed in this thesis. The ability to predict glucose along a given prediction horizon, and estimation of future glucose trends, is the most important feature of any artificial pancreas system, in order to be able to take preventive actions to entirely avoid risk to the patient. Glucose prediction can appear as part of the control algorithm itself, such as in systems based on model predictive control (MPC) techniques, or as part of a monitoring system to avoid hypoglycemic episodes. However, predicting glucose is a very challenging problem due to the large inter- and intra-subject variability that patients suffer, whose sources are only partially understood. These limits models forecasting performance, imposing relatively short prediction horizons, despite the modeling technique used (physiological, data-driven or hybrid approaches). The starting hypothesis of this thesis is that the complexity of glucose dynamics requires the ability to characterize clusters of behaviors in the patient's historical data naturally yielding to the concept of local modeling. Besides, the similarity of responses in a cluster can be further exploited to introduce the classical concept of seasonality into glucose prediction. As a result, seasonal local models are at the core of this thesis. Several clinical databases including mixed meals and exercise are used to demonstrate the feasibility and superiority of the performance of this approach., This work has been supported by the Spanish Ministry of Economy and Competitiveness (MINECO) under the FPI grant BES-2014-069253 and projects DPI2013-46982-C2-1-R and DPI2016-78831-C2-1-R. Moreover, with relation to this grant, a short stay was done at the end of 2017 at the Illinois Institute of Technology, Chicago, United States of America, under the supervision of Prof. Ali Cinar, for four months from 01/09/2017 to 29/12/2017.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Extensive assessment of blood glucose monitoring during postprandial period and its impact on closed-loop performance

  • Biagi, L.
  • Hirata-Bertachi, A.
  • Conget, I.
  • Quirós, C.
  • Giménez, M.
  • Ampudia-Blasco, F.J.
  • Rossetti, P.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Closed-loop (CL) systems aims to outperform usual treatments in blood glucose control and continuous glucose monitors (CGM) are a key component in such systems. Meals represents one of the main disturbances in blood glucose control, and postprandial period (PP) is a challenging situation for both CL system and CGM accuracy. Methods: We performed an extensive analysis of sensor¿s performance by numerical accuracy and precision during PP, as well as its influence in blood glucose control under CL therapy. Results: During PP the mean absolute relative difference (MARD) for both sensors presented lower accuracy in the hypoglycemic range (19.4 ± 12.8%) than in other ranges (12.2 ± 8.6% in euglycemic range and 9.3 ± 9.3% in hyperglycemic range). The overall MARD was 12.1 ± 8.2%. We have also observed lower MARD for rates of change between 0 and 2 mg/dl. In CL therapy, the 10 trials with the best sensor spent less time in hypoglycemia (PG < 70 mg/dl) than the 10 trials with the worst sensors (2 ± 7 minutes vs 32 ± 38 minutes, respectively). Conclusions: In terms of accuracy, our results resemble to previously reported. Furthermore, our results showed that sensors with the lowest MARD spent less time in hypoglycemic range, indicating that the performance of CL algorithm to control PP was related to sensor accuracy., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has been partially supported by the Spanish Government through Grants DPI 2013-46982-C2-1-R, DPI 2016-78831-C2-1-R, DPI 2013-46982-C2-2-R, and DPI 2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Sliding-mode disturbance observers for an artificial pancreas without meal announcement

  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Diez, José-Luís|||0000-0002-5659-1212
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Carbohydrate counting is not only a burden for patients with type 1 diabetes, but estimation errors in meal announcement could also degrade the outcomes of the current hybrid closed-loop systems. Therefore, removing meal announcement is desirable. A novel control system is addressed here to face postprandial control without meal announcement. The proposed system grounds on two applications of the sliding mode observers in dealing with disturbances: first, the equivalent output technique is used to reconstruct the meal rate of glucose appearance via a first order sliding mode observer; second, a super-twisting -based residual generator is used to detect the meals. Subsequently, a bolusing algorithm uses the information of the two observers to trigger a series of boluses based on a proportional-derivative-like strategy. An in silico validation with 30 patients in a 30-day scenario reveals that the meal detector algorithm achieves a low rate of false positives per day (0.1 (0.1), mean (SD)) and a detection time of 28.5(6.2) min. Additionally, the bolusing algorithm fulfills a non-statistically different mean glucose than the hybrid counterpart with bolus misestimation (146.69 (12.20) mg/dLvs. 144.28 (11.01) mg/dL,p>0.05), without increasing hypoglycemia (0.029 (0.077) vs. 0.004 (0.014)%, p > 0,05), although at the expense of a slightly higher time in hyperglycemia (22.51(8.72) % vs. 18.65 (7.89)%, p <0.05) due to the conservative tuning of the bolusing algorithm for the sake of safety., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) [grant number DPI2016-78831-C2-1-12]; the European Union [FEDER funds]: and Generalitat Valenciana [grant number ACIF/2017/021]
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Comprehensive Review of Continuous Glucose Monitoring Accuracy during Exercise Periods

  • Muñoz Fabra, Elena
  • Laguna Sanz, Alejandro José
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous Glucose Monitoring (CGM) has been a springboard of new diabetes management technologies such as integrated sensor-pump systems, the artificial pancreas, and more recently, smart pens. It also allows patients to make better informed decisions compared to a few measurements per day from a glucometer. However, CGM accuracy is reportedly affected during exercise periods, which can impact the effectiveness of CGM-based treatments. In this review, several studies that used CGM during exercise periods are scrutinized. An extensive literature review of clinical trials including exercise and CGM in type 1 diabetes was conducted. The gathered data were critically analysed, especially the Mean Absolute Relative Difference (MARD), as the main metric of glucose accuracy. Most papers did not provide accuracy metrics that differentiated between exercise and rest (non-exercise) periods, which hindered comparative data analysis. Nevertheless, the statistic results confirmed that CGM during exercise periods is less accurate., This work was supported by the Ministerio de Economía, Industria y Competitividad (MINECO), Grant Number DPI2016-78831-C2-1-R, the Agencia Estatal de Investigación PID2019-107722RB-C21 / AEI /10.13039/501100011033, the European Union (FEDER funds), and the Vicerectorate of Research, Innovation and Technology Transference from the Universitat Politècnica de València (Grant Number PAID-06-18).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Super-twisting-based meal detector for type 1 diabetes management: Improvement and assessment in a real-life scenario

  • Faccioli, S.
  • Facchinetti, A.
  • Sparacino, G.
  • del Favero, S.
  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to improve postprandial control in type 1 diabetes. However, this is an extra burden on subjects, and it introduces a source of potential errors that could impact control performances. In fact, carbohydrates estimation is challenging, prone to errors, and it is known that subjects sometimes struggle to adhere to this requirement, forgetting to perform this task. A possible solution is the use of automated meal detection algorithms. In this work, we extended a super-twisting-based meal detector suggested in the literature and assessed it on real-life data. Methods: To reduce the false detections in the original meal detector, we implemented an implicit discretization of the super-twisting and replaced the Euler approximation of the glucose derivative with a Kalman filter. The modified meal detector is retrospectively evaluated in a challenging real-life dataset corresponding to a 2-week trial with 30 subjects using sensor-augmented pump control. The assessment includes an analysis of the nature and riskiness of false detections. Results: The proposed algorithm achieved a recall of 70 [13] % (median [interquartile range]), a precision of 73 [26] %, and had 1.4 [1.4] false positives-per-day. False positives were related to rising glucose conditions, whereas false negatives occurred after calibrations, missing samples, or hypoglycemia treatments. Conclusions: The proposed algorithm achieves encouraging performance. Although false positives and false negatives were not avoided, they are related to situations with a low risk of hypoglycemia and hyperglycemia, respectively., This work was supported by grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"; grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; the Generalitat Valenciana through FSE funds (grant number ACIF/2017/021); the Italian Ministry of Education, Universities and Research (MIUR) through the project "Learn4AP: Patient-Specific Models for an Adaptive, Fault Tolerant Artificial Pancreas"(SIR initiative, project ID: RBSI14JYM2); the MIUR under the initiative "Departments of Excellence"(Law 232/2016).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus

  • Biagi, L.
  • Bertachi, A.
  • Quirós, C.
  • Giménez, M.
  • Conget, I.
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes management as well as for CGM systems. In this work, the accuracy of CGM in the context of exercise is addressed. Six adults performed aerobic and anaerobic exercise sessions and used two Medtronic Paradigm Enlite-2 sensors under closed-loop therapy. CGM readings were compared with plasma glucose during different periods: one hour before exercise, during exercise, and four hours after the end of exercise. In aerobic sessions, the median absolute relative difference (MARD) increased from 9.5% before the beginning of exercise to 16.5% during exercise (p < 0.001), and then decreased to 9.3% in the first hour after the end of exercise (p < 0.001). For the anaerobic sessions, the MARD before exercise was 15.5% and increased without statistical significance to 16.8% during exercise realisation (p = 0.993), and then decreased to 12.7% in the first hour after the cessation of anaerobic activities (p = 0.095). Results indicate that CGM might present lower accuracy during aerobic exercise, but return to regular operation a few hours after exercise cessation. No significant impact for anaerobic exercise was found., This project was partially supported by the Spanish Government through grants DPI2013-46982-C2-1-R, DPI2013-46982-C2-2-R, DPI2016-78831-C2-1-R, and DPI2016-78831-C2-2-R, and by the National Council of Technological and Scientific Development, CNPq Brazil through grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Impact of High Intensity Interval Training Using Elastic Bands on Glycemic Control in Adults with Type 1 Diabetes: A Pilot Study

  • Martín-San Agustín, Rodrigo
  • Laguna Sanz, Alejandro José
  • Roche, Enrique
  • Benítez Martínez, Josep C.
  • Ampudia-Blasco, F. Javier
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] High intensity interval training (HIIT) using elastic bands is easy to do, but no data on its impact on glycemic control in people with type 1 diabetes (T1D) are available. Six males with T1D performed three weekly sessions of HIIT using elastic bands for 12 weeks. Each session consisted of eight exercises. Glycemic control was evaluated by using intermittent scanning continuous glucose monitoring two weeks before study onset (baseline) and during the intervention period in the first two (first stage) and last two weeks (last stage). In the 24 h post-exercise, time-in-range (70-180 mg/dL) was reduced from baseline to the end of the study (67.2% to 63.0%), and time-above-range (>180 mg/dL) seemed to increase from baseline across the study (20.8% -> 27.5% -> 22.1%, from baseline -> first -> last stage), but did not show any statistical significance. Time in hypoglycemia (either < 70 mg/dL or <54 mg/dL) did not show statistically significant differences. This study shows that a HIIT program with elastic bands is safe and effective to perform in T1D patients, keeping blood glucose levels in a safe range., This study was funded by MINECO DPI2016-78831-C2-1-R, Agencia Estatal de Investigacion (PID2019-107722RB-C21/AEI/10.13039/501100011033), FEDER funds from EU, and the Vicerectorate of Research, Innovation and Technology Transference from the Universitat Politecnica de Valencia grant number PAID-06-18. This study was also supported by the official funding agency for biomedical research of the Spanish government, Institute of Health Carlos III (ISCIII) through CIBEROBN CB12/03/30038, and CIBERDEM CB17/08/00004, which is co-funded by the European Regional Development Fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A first cubic upper bound on the local reachability index for some positive 2-D systems

  • Bailo Ballarín, Esteban
  • Gelonch, Josep
  • Romero Vivó, Sergio|||0000-0001-6689-4324
[EN] The calculation of the smallest number of steps needed to deterministically reach all local states of an nth-order positive 2-D system, which is called local reachability index (ILR) of that system, was recently tackled bymeans of the use of a suitable composition table. The greatest index ILR obtained in the previous literature was n+3 ([n/2]) 2 for some appropriated values of n. Taking as a basis both a combinatorial approach of such systems and the construction of suitable geometric sets in the plane, an upper bound on ILR depending on the dimension n for a new family of systems is characterized. The 2-D influence digraph of this family of order n = 6 consists of two subdigraphs corresponding to a unique source s. The first one is a cycle involving the first n(1) vertices and is connected to the another subdigraph through the 1-arc (2, n(1) +n(2)), being the natural numbers n(1) and n(2) such that n(1) > n(2) = 2 and n-n(1)-n(2) = 1. The second one has two main cycles, a cycle where only the remaining vertices n(1)+1,..., n appear and a cycle containing only the vertices n(1)+1, n(1)+n(2)-1. Moreover, the last vertices are connected through the 2-arc (n(1) +n(2)-1, n). Furthermore, if n > 12 and is a multiple of 3, for appropriate n(1) and n(2), the ILR of that family is at least cubic, exactly, it must be n(3)+9n(2)+45n+108/27, which shows that some local states can be deterministically reached much further than initially proposed in the literature., We are gratefully thankful to the reviewers for their valuable remarks. This work has been partially supported by the European Union [FEDER funds] and Ministerio de Ciencia e Innovacion through Grants MTM-2013-43678-P and DPI2016-78831-C2-1-R.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomized crossover trial

  • García, Alia
  • Moscardo-Garcia, Vanessa
  • Ramos-Prol, Agustín
  • Diaz, Julián
  • Boronat, Miguel
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Introduction Meal composition is known to affect glycemic variability and glucose control in type 1 diabetes. The objective of this work was to evaluate the effect of high carbohydrate meals of different nutritional composition and alcohol on the postprandial glucose response in patients with type 1 diabetes. Research design and methods Twelve participants were recruited to this randomized crossover trial. Following a 4-week run-in period, participants received a mixed meal on three occasions with the same carbohydrate content but different macronutrient composition: high protein-high fat with alcohol (0.7g/kg body weight, beer), high protein-high fat without alcohol, and low protein-low fat without alcohol at 2-week intervals. Plasma and interstitial glucose, insulin, glucagon, growth hormone, cortisol, alcohol, free fatty acids, lactate, and pH concentrations were measured during 6 hours. A statistical analysis was then carried out to determine significant differences between studies. Results Significantly higher late postprandial glucose was observed in studies with higher content of fats and proteins (p=0.0088). This was associated with lower time in hypoglycemia as compared with the low protein and fat study (p=0.0179), at least partially due to greater glucagon concentration in the same period (p=0.04). Alcohol significantly increased lactate, decreased pH and growth hormone, and maintained free fatty acids suppressed during the late postprandial phase (p<0.001), without significant changes in plasma glucose. Conclusions Our data suggest that the addition of proteins and fats to carbohydrates increases late postprandial blood glucose. Moreover, alcohol consumption together with a mixed meal has relevant metabolic effects without any increase in the risk of hypoglycemia, at least 6 hours postprandially., This paper presents independent research financially supported by Ministerio de Economia y Competitividad (MINECO) (DPI2016--78831-C2--1--R), Agencia Estatal de Investigacion (PID2019--107722RB--C21/AEI/10.13039/501100011033), and the European Union through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Near-optimal feedback control for postprandial glucose regulation in type 1 diabetes

  • Sanz Diaz, Ricardo
  • García Gil, Pedro José|||0000-0002-1202-1269
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] This paper is focused on feedback control of postprandial glucose levels for patients with type 1 Diabetes Mellitus. There are two important limitations that make this a challenging problem. First, the slow subcutaneous insulin pharmacokinetics that introduces a significant lag into the control loop. Second, the positivity constraint on the control action, meaning that it is not possible to remove insulin from the body. In this paper, both issues are explicitly considered in the design process using the internal model control framework, to derive a near-optimal feedback controller. Optimality is understood here as minimizing the blood glucose peak after a meal intake and, at the same time, preventing glucose values below a prescribed threshold. It is shown how the proposed controller approaches the optimal closed-loop performance as a limit case. The theoretical results are supported by a numerical example and the feasibility of the overall strategy under uncertainties is illustrated using an extended version UVa/Padova metabolic simulator. (c) 2022 Published by Elsevier Ltd on behalf of ISA., This work was partially supported by: grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"; grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; grant PAID-10-19 funded by Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Enhanced Accuracy of Continuous Glucose Monitoring during Exercise through Physical Activity Tracking Integration

  • Laguna Sanz, Alejandro José
  • Giménez, Marga
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Current Continuous Glucose Monitors (CGM) exhibit increased estimation error during periods of aerobic physical activity. The use of readily-available exercise monitoring devices opens new possibilities for accuracy enhancement during these periods. The viability of an array of physical activity signals provided by three different wearable devices was considered. Linear regression models were used in this work to evaluate the correction capabilities of each of the wearable signals and propose a model for CGM correction during exercise. A simple two-input model can reduce CGM error during physical activity (17.46% vs. 13.8%, p < 0.005) to the magnitude of the baseline error level (13.61%). The CGM error is not worsened in periods without physical activity. The signals identified as optimal inputs for the model are Mets (Metabolic Equivalent of Tasks) from the Fitbit Charge HR device, which is a normalized measurement of energy expenditure, and the skin temperature reading provided by the Microsoft Band 2 device. A simpler one-input model using only Mets is also viable for a more immediate implementation of this correction into market devices., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) (Grant Number DPI2016-78831-C2-1-R), the European Union (FEDER funds), and the Vicerectorate of Research, Innovation and Technology Transference from the Universitat Politecnica de Valencia (Grant Number PAID-06-18). We would like to acknowledge the work performed by Josep Vehí, Lyvia Biagi, Ignacio Conget and Carmen Quirós. We thank all the participants and clinical staff who participated in clinical acquisition and pre-formatting of data for study, without whom none of this work would have been possible.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effect of Ethanol Consumption on the Accuracy of a Glucose Oxidase-Based Subcutaneous Glucose Sensor in Subjects with Type 1 Diabetes

  • Moscardó, Vanessa
  • Garcia, Alia
  • Diaz, Julián
  • Ramos-Prol, Agustín
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous glucose monitors (CGM) have improved the management of patients with type 1 diabetes (T1D), with glucose oxidase (GOx)-based sensors being the most used. However, they are potentially subject to both electrochemical and enzymatic interferences, including those related to changes of pH. The objective of this study is to investigate the effect of ethanol, given as beer along with a mixed meal, on the accuracy of a commercial GOx-CGM. Data from 12 T1D participants in a randomized crossover trial to evaluate the effect of meal composition and alcohol consumption on postprandial glucose concentration were used. Absolute error (AE) and mean absolute relative difference (MARD) were calculated. The differences between the alcohol and nonalcohol scenarios were assessed using the Mann-Whitney U and Wilcoxon signed-rank tests. The AE in the alcohol study was low, but significantly greater as compared to the study without alcohol (p-value = 0.0418). The MARD was numerically but not significantly greater. However, both variables were greater at pH < 7.36 and significantly affected by time only in the alcohol arm. In T1D, alcohol consumption affects the accuracy of a GOx-CGM. This effect could be at least partially related to the ethanol-induced changes in pH., This research was funded by grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"; and grant PID2019-107722RBC21 funded by MCIN/AEI/10.13039/501100011033.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A New Blood Glucose Control Scheme for Unannounced Exercise in Type 1 Diabetic Subjects

  • Beneyto, Aleix
  • Bertachi, Arthur
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The artificial pancreas (AP) system or closed-loop blood glucose (BG) regulation is a technological advancement that aims to relieve diabetic subjects from their current decision-making burden while tightening their BG levels. However, large disturbances such as meals and exercise still pose great challenges to a fully closed-loop system. In this paper, the problem of BG regulation with unannounced physical activity for type 1 diabetic subjects is addressed. We use a coordinated control strategy with insulin infusion and extra carbohydrates (CHO) for hypoglycemia avoidance. The insulin algorithm is based on a proportional-derivative controller with insulin feedback and the so-called safety auxiliary feedback element (SAFE) layer, and the algorithm for CHO is based on a predictive, quantified proportional-derivative controller. The UVa/Padua simulator glucose-insulin model is modified to include the effects of physical activity and is used to test the new AP. We consider scenarios where the subject does not announce physical activity and with challenging meals. Then, we analyze the performance and robustness of the combined insulin and CHO recommender system and compare them to the insulin-only controller. The simulation results show that the new AP system is able to mitigate daily hypoglycemia episodes (0.9 versus 0.2, p < 0.01) and increase the time in range during day (91.5% versus 92.4%, p < 0.01) without increasing the time above 180 mg/dl (6.3% versus 6.4%, p > 0.05)., This work was supported in part by the Ministerio de Economia, Industria y Competitividad under Grant DPI2016-78831-C2-1-R and Grant DPI2016-78831-C2-2-R, in part by the Autonomous Government of Catalonia under Grant 2017 SGR 1551, in part by the Ministerio de Educacion, Cultura y Deporte under Grant FPU0244 2015, in part by the National Counsel of Technological and Scientific Development, CNPq, Brazil, under Grant 207688/2014-1, and in part EU through FEDER funds. Recommended by Associate Editor D. E. Rivera.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Glucose Prediction under Variable-Length Time-Stamped Daily Events: A Seasonal Stochastic Local Modeling Framework

  • Montaser, Eslam
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Accurate glucose prediction along a long-enough time horizon is a key component for technology to improve type 1 diabetes treatment. Subjects with diabetes might benefit from supervision and control systems that accurately predict risks and trigger corrective actions early enough with improved mitigation. However, large intra-patient variability poses big challenges to glucose prediction. In previous works by the authors, clustering and local modeling techniques with seasonal stochastic models proved to be efficient, allowing for good glucose prediction accuracy for long prediction horizons. Continuous glucose monitoring (CGM) data were partitioned into fixed-length postprandial time subseries and clustered with Fuzzy C-Means to collect similar behaviors, enforcing seasonality at each cluster after subseries concatenation. Then, seasonal stochastic models were identified for each cluster and local predictions were integrated into a global prediction. However, free-living conditions do not support the fixed-length partition of CGM data since daily events duration is variable. In this work, a new algorithm is provided to overcome this constraint, allowing better coping with patient's variability under variable-length time-stamped daily events in supervision and control applications. Besides predicted glucose, two real-time indices are additionally provided-a crispness index, indicating good representation of current glucose behavior by a single model, and a normality index, allowing for the detection of an abnormal glucose behavior (unusual according to registered historical data). The framework is tested in a proof-of-concept in silico study with ten patients over four month training data and two independent two month validation datasets, with and without abnormal behaviors, from the distribution version of the UVA/Padova simulator extended with diverse sources of intra-patient variability., This work was supported by the Ministerio de Economia, Industria y Competitividad (MINECO), Grant Number DPI2016-78831-C2-1-R, the Agencia Estatal de Investigacion PID2019107722RB-C21/AEI/10.13039/501100011033, and the European Union (FEDER funds).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Parallel Control of an artificial pancreas with coordinated insulin, glucagon and rescue carbohydrate control actions

  • Moscardo-Garcia, Vanessa
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: An artificial pancreas with insulin and glucagon delivery has the potential to reduce the risk of hypo- and hyperglycemia in people with type 1 diabetes. However, a maximum dose of glucagon of 1 mg/d is recommended, potentially still requiring rescue carbohydrates in some situations. This work presents a parallel control structure with intrinsic insulin, glucagon, and rescue carbohydrates coordination to overcome glucagon limitations when needed. Methods: The coordinated controller that combines insulin, glucagon, and rescue carbohydrate suggestions (DH-CC-CHO) was compared with the insulin and glucagon delivery coordinated controller (DH-CC). The impact of carbohydrate quantization for practical delivery was also assessed. An in silico study using the UVA-Padova simulator, extended to include exercise and various sources of variability, was performed. Results: DH-CC and DH-CC-CHO performed similarly with regard to mean glucose (126.25 [123.43; 130.73] vs 127.92 [123.99; 132.97] mg/dL, P = .088), time in range (93.04 [90.00; 95.92] vs 92.91 [90.05; 95.75]%, P = .508), time above 180 mg/dL (4.94 [2.72; 7.53] vs 4.99 [2.93; 7.24]%, P = .966), time below 70 mg/dL (0.61 [0.09; 1.75] vs 0.96 [0.23; 2.17]%, P = .1364), insulin delivery (43.50 [38.68; 51.75] vs 42.86 [38.58; 51.36] U/d, P = .383), and glucagon delivery (0.75 [0.40; 1.83] vs 0.76 [0.43; 0.99] mg/d, P = .407). Time below 54 mg/dL was different (0.00 [0.00; 0.05] vs 0.00 [0.00; 0.16]%, P = .036), although non-clinically significant. This was due to the carbs quantization effect in a specific patient, as no statistical difference was found when carbs were not quantized (0.00 [0.00; 0.05] vs 0.00 [0.00; 0.00]%, P = .265). Conclusions: The new strategy of automatic rescue carbohydrates suggestion in coordination with insulin and glucagon delivery to overcome constraints on daily glucagon delivery was successfully evaluated in an in silico proof of concept., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) through grant number DPI2016-78831-C2-1-R and the European Union through FEDER funds. Vanessa Moscardó was recipient of an FPU grant, FPU13/04253.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

New Contributions Towards Meal and Exercise Announcement-Free Artificial Pancreas Systems

  • Sala-Mira, Iván|||0000-0002-6228-5190
[ES] Las infusiones exógenas de insulina son vitales para las personas con diabetes tipo 1 para suplir parcialmente la incapacidad del páncreas de secretar insulina. Sin embargo, las terapias intensivas actuales pueden restringir la calidad de vida de los pacientes. Los pacientes con esta enfermedad tienen que tomar decisiones constantemente sobre las dosis de insulina que lleva a la glucosa a niveles seguros. Si no lo consiguen, pueden sufrir las complicaciones crónicas y agudas derivadas de los niveles anormalmente altos o bajos de glucosa. La regulación automática de glucosa con sistemas de páncreas artificial prometía reducir la carga del autocontrol de la enfermedad al mismo tiempo que se mejoraba el tiempo en normoglucemia y se reducía la variabilidad. Sin embargo, estas promesas sólo se han cumplido parcialmente. Aunque esta tecnología mejora el control glucémico que logran las terapias tradicionales, la ingesta de alimentos y la práctica de ejercicio limitan la eficiencia de los sistemas de páncreas artificial durante el día. De hecho, los sistemas comerciales sólo pueden hacerles frente con la ayuda de los pacientes. Para compensar las ingestas, los pacientes deben anunciar el contenido de carbohidratos al sistema. Para el ejercicio, deben anunciar el inicio de la actividad o tomar medidas preventivas como modificar la referencia de glucosa o reducir la basal con mucha antelación. Estas exigencias no sólo no ayudan a reducir la carga del paciente, sino que pueden comprometer la eficiencia del sistema cuando el paciente se equivoca al estimar los carbohidratos, omite el anuncio de la comida o no puede planificar el ejercicio. Así pues, esta tesis propone nuevos métodos para eliminar el anuncio de ingestas y ejercicio lo que ayudaría a reducir la intervención del paciente en los sistemas de páncreas artificial, y, en consecuencia, mejorar la calidad de vida. Desde un punto de vista de control, las ingestas y el ejercicio pueden considerarse perturbaciones. Esta tesis explota métodos de la literatura de rechazo de perturbaciones y acomodación de fallos para lograr el objetivo de la tesis. En concreto, hay que destacar tres aplicaciones: 1) se ha desarrollado un observador super-twisting para detectar comidas no anunciadas como primer paso para su compensación; 2) se ha diseñado un observador de modos deslizantes de primer orden para la estimación de la ratio de aparición de glucosa, la cual ha sido integrada en un generador de bolos para compensar las comidas; 3) se ha empleado el principio de diseño por modelo interno para mitigar el efecto de las ingestas de alimentos y ejercicio, añadiendo sugerencias de carbohidratos de rescate a la insulina. Como resultado, las contribuciones de esta tesis allanan el camino para el desarrollo de sistemas de páncreas artificial sin anuncios, que liberen al paciente de la carga de la gestión de la diabetes., [CA] Les infusions exògenes d'insulina són vitals per a les persones amb diabetis tipus 1 per a suplir parcialment l'incapacitat del pàncrees de secretar insulina. No obstant, les teràpies intensives actuals poden restringir la qualitat de vida dels pacients. Les persones amb aquesta malaltia han de prendre decisions contínuament sobre la dosi d'insulina que fa que la glucosa estiga en valors segurs. Si no ho aconsegueixen, poden sofrir les complicacions cròniques i agudes derivades dels nivells anormalment alts o baixos de glucosa. La regulació automàtica de glucosa amb sistemes de pàncrees artificials prometia reduir la càrrega d'autocontrol de la malaltia al mateix temps que es millorava el temps en normoglucèmia i es reduïa la variabilitat. No obstant, aquestes promeses s'han complit només parcialment. Encara que aquesta tecnologia millora el control de la glucosa, la ingesta d'aliments i la pràctica d'exercici limiten l'eficiència dels sistemes de pàncrees artificials durant el dia. De fet, els sistemes comercials només poden fer-les front amb la ajuda dels pacients. Per a compensar les ingestes, el pacients han d'anunciar al sistema la quantitat de carbohidrats. Per al exercici, han d'anunciar l'inici de l'activitat o prendre mesures preventives com modificar la referència de glucosa o reduir la infusió basal d'insulina. Aquestes exigències no només no ajuden a reduir la càrrega al pacient, sinó que poden comprometre l'eficiència del sistema quan el pacient confon la estimació dels carbohidrats, omet l'anunciament de la ingesta o no pot planificar l'exercici. Així doncs, aquesta tesi proposa nous mètodes per a eliminar l'anunciament d'ingestes i exercici permetent reduir així la intervenció del pacient, i, en conseqüència, millorar la qualitat de vida. Des del punt de vista de control, les ingestes i el exercici poden considerar-se pertorbacions. Aquesta tesi explota mètodes de la literatura de rebuig de pertorbacions i acomodament de fallades. En particular, es destaquen tres aplicacions: 1) s'ha desenvolupat un observador super-twisting per a detectar ingestes no anunciades com a primer pas per a la seua compensació; 2) se ha dissenyat un observador de modes lliscants per a estimar el rati d'aparició de glucosa de la ingesta, el qual s'ha integrat en un generador de bols d'insulina per compensar les ingestes; 3) se ha empleat el principi de disseny per model intern per a mitigar l'efecte de les ingestes i exercici, incorporant recomanacions de carbohidrats a la insulina. Com a resultat, les contribucions d'aquesta tesi obren el camí per a desenvolupar sistemes de pàncrees artificial sense anunciaments, que alliberen al pacient de la càrrega de la gestió de la diabetis., [EN] Exogenous insulin infusions are vital for people with type 1 diabetes to partially make up for the inability of the pancreas to secrete insulin. However, current intensive therapies may restrict patients' quality of life. People with this disease have to constantly make decisions about insulin doses to bring glucose levels to a safe range. If unsuccessful, they may suffer from chronic and acute complications related to abnormally high and low glucose values. The automatic regulation of glucose with artificial pancreas systems promised to reduce patients' self-control burdens while improving time in normoglycemia and decreasing variability. However, these promises are fulfilled only partially. Although this technology outperforms the glycemic outcomes achieved by conventional therapies, meal intake and physical activity limit its daytime performance. Indeed, commercially available systems only can handle them with the support of the patients. For meals, patients must announce the carbohydrate content to the system. For exercise, they must notify the activity or take preventive actions like changing glucose setpoint or decreasing basal well ahead before exercise. These demands do not help reduce the patient's burden. They even can compromise the system performance when the patient misestimates the carbohydrate content, omits the meal announcement, or cannot plan the exercise event. Hence, this thesis proposes new methods to eliminate the need for meal and exercise announcements, thus reducing patient intervention in artificial pancreas systems for a better quality of life. From a control perspective, meals and exercise can be regarded as disturbances; therefore, this thesis exploits methods from the disturbance rejection and fault accommodation literature to achieve the thesis goal. Specifically, the following three applications must be highlighted: 1) a super-twisting-based residual generator has been developed to detect unannounced meals as the first step to their compensations; 2) a sliding-mode disturbance observer has been designed to estimate the glucose meal appearance, which is fed into a bolusing algorithm to compensate the meals; 3) the internal model principle is employed to mitigate the effects of meal intakes and exercise, supplementing insulin infusions with carbohydrate recommendations. As a result, the contributions of this thesis pave the way for the development of announcement-free artificial pancreas systems, releasing patients from the burden of diabetes management., This work was partially supported by: grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; and grant ACIF/2017/021 funded by the Generalitat Valenciana through European Social Funds (FSE). Also, the grant BEFPI/2019/077, funded by the Generalitat Valenciana through FSE funds, supported a 7-month research stay at Physiological da University (Óbudai Egyetem, Óbuda, Budapest, Hungary)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Stochastic Seasonal Models for Glucose Prediction in the Artificial Pancreas

  • Montaser Roushdi Ali, Eslam
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Linear empirical dynamic models have been widely used for glucose prediction. The extension of the concept of seasonality, characteristic of other domains, is explored here for the improvement of prediction accuracy. Methods: Twenty time series of 8-hour postprandial periods (PP) for a same 60g-carbohydrate meal were collected from a closed-loop controller validation study. A single concatenated time series was produced representing a collection of data from similar scenarios, resulting in seasonality. Variability in the resulting time series was representative of worstcase intrasubject variability. Following a leave-one-out cross-validation, seasonal and nonseasonal autoregressive integrated moving average models (SARIMA and ARIMA) were built to analyze the effect of seasonality in the model prediction accuracy. Further improvement achieved from the inclusion of insulin infusion rate as exogenous variable was also analyzed. Prediction horizons (PHs) from 30 to 300 min were considered. Results: SARIMA outperformed ARIMA revealing a significant role of seasonality. For a 5-h PH, average MAPE was reduced in 26.62%. Considering individual runs, the improvement ranged from 6.3% to 54.52%. In the best-performing case this reduction amounted to 29.45%. The benefit of seasonality was consistent among different PHs, although lower PHs benefited more, with MAPE reduction over 50% for PHs of 60 and 120 minutes, and over 40% for 180 min. Consideration of insulin infusion rate into the seasonal model further improved performance, with a 61.89% reduction in MAPE for 30-min PH and reductions over 20% for PHs over 180 min. Conclusions: Seasonality improved model accuracy allowing for the extension of the PH significantly., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the Spanish Ministry of Economy and Competitiveness, grants DPI2013-46982-C2-1-R and DPI2016-78831-C2-1-R, and the European Union through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

  • Moscardo-Garcia, Vanessa
  • Ampudia-Blasco, Francisco Javier
  • Fanelli, Carmine G
  • Lucidi, Paola
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Continuous glucose monitoring (CGM) accuracy during hypoglycemia is suboptimal. This might be partly explained by insulin or hypoglycemia-induced changes in the plasma interstitial subcutaneous (SC) fluid glucose gradient. The aim of the present study was to assess the role of plasma insulin (PI) and hypoglycemia itself in the plasma and interstitial SC fluid glucose concentration in patients with type 1 diabetes mellitus. Methods: Eleven subjects with type 1 diabetes (age 36.59.1 years, HbA(1c) 7.90.4% [62.8 +/- 2.02mmol/mol]; mean +/- standard deviation) were evaluated under hyperinsulinemic euglycemia and hypoglycemia. Each subject underwent two randomized crossover clamps with either a primed 0.3 (low insulin) or 1mU/(kgmin) (high insulin) insulin infusion. The raw CGM signal was normalized with median preclamp values to obtain a standardized measure of the interstitial glucose (IG) concentration before statistical analysis. Results: The mean PI concentration was greater in high insulin studies (HISs) versus low insulin studies (LISs) (412.89 +/- 13.63 vs. 177.22 +/- 10.05pmol/L). During hypoglycemia, glucagon, adrenaline, free fatty acids, glycerol, and beta-OH-butyrate were higher in the LIS (P<0.0001). Likewise, the IG concentration was significantly different (P<0.0001). This was due to lower IG concentration than plasma glucose (PG) concentration during the euglycemic hyperinsulinemic phases in the HIS. In contrast, no difference was observed during hypoglycemia. This was the result of an unchanged PG/IG gradient during the entire LIS, while in the HIS, this gradient increased during the hyperinsulinemic euglycemia phase. Conclusion: Both PI levels and hypoglycemia affect the relationship between IG and PG concentration. ClinicalTrials.gov Identifier: NCT01714895., The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007/2013) under the grant agreement 252085 and FEDER funds, as well as the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants DPI2013-46982-C2-1-R and DPI2016-78831-C2-1-R.V.M. is recipient of an FPU grant ref FPU13/04253. We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study.